Doktor axborotnomasi 2025, № (117)
Subject of the article
RESULTS OF EXTENDED AND COMBINED SURGICAL METHODS FOR ADVANCED STOMACH CANCER (167-171)
Authors
A. A. Kuliev1, M. D. Juraev2, F. G. Ulmasov1
Institution
1Samarkand state medical university, Samarkand, 2Republican specialized scientific and practical medical center of oncology and radiology, Tashkent, Uzbekistan
Abstract
In this study, pancreatic involvement was observed in 91.2% of cases in T4 gastric cancer. Moreover, with the same frequency (34.5%), ingrowth into the pancreas was combined with damage to the transverse colon and around vessels. The prognostic factors that determine the survival of patients with T4 gastric cancer remain unclear. Data on the immediate results of combined operations performed for locally pervasive gastric cancer vary considerably in the literature. The frequency of postoperative complications ranges from 5 to 59.4%, postoperative mortality - from 3.3 to 24.2%. The optimal surgical tactics for the treatment of patients with locally widespread gastric cancer has not been determined. Not only the indications for combined resections and palliative interventions remain controversial, but also the immediate and long-term results of treatment, which determines the relevance of continuing research.
Key words
stomach cancer, locally widespread, combined operations, palliative gastrectomy.
Literature
1. Delaunoit, T. "Latest developments and emerging treatment options in the management of stomach can cer." (2011). ncbi.nlm.nih.gov 2. Paulo Batista, T. and Rino Martins, M. "Lymph node dissection for gastric cancer: a critical review." (2012). ncbi.nlm.nih.gov 3. Li, M., Deng, L., Wang, J., Xiao, L., Wu, W., Yang, S., and Li, W. "Surgical Outcomes and Prognostic Factors of T4 Gastric Cancer Patients without Distant Metastasis." (2014). ncbi.nlm.nih.gov 4. Petrillo, A., Pompella, L., Tirino, G., Pappalardo, A., Maddalena Laterza, M., Caterino, M., Orditura, M., Ciardiel lo, F., Lieto, E., Galizia, G., Castoro, C., and De Vita, F. "Perioperative Treatment in Resectable Gastric Cancer: Current Perspectives and Future Directions." (2019). ncbi.nlm.nih.gov 5. Wang, G. C., Liu, Y. J., Gao, C. Q., Wang, Y. C., Lv, H. F., Chen, B. B., Nie, C. Y., Chen, X. B., and Luo, S. X. "Surgical outcomes and survival for T4 gastric cancer extending to the transverse colon." (2020). ncbi.nlm.nih.gov 6. Johannes Pflüger, M., Felsenstein, M., Schmocker, R., DeLong Wood, L., Hruban, R., Fujikura, K., Rozich, N., van Oosten, F., Weiss, M., Burns, W., Yu, J., Cameron, J., Pratschke, J., Lee Wolfgang, C., He, J., and Andrew Burkhart, R. "Gastric cancer following pancreaticoduodenectomy: Experience from a high-volume center and re view of existing literature." (2020). ncbi.nlm.nih.gov 7. Nakamura, N., Kinami, S., Fujita, J., Kaida, D., Tomita, Y., Miyata, T., Fujita, H., Ueda, N., and Takamura, H. "Advanced gastric cancer with abdominal wall invasion treated with curative resection after chemotherapy: a case report." (2021). ncbi.nlm.nih.gov 8. Varga, Z., Kolozsi, P., Nagy, K., and Tóth, D. "Optimal extent of lymph node dissection in gastric cancer." (2022). ncbi.nlm.nih.gov 9. Kuliev A.A., Juraev M.D. и др. // Turkish Journal of Physiotherapy and Rehabilitation; 32(3) 2021. C 7242-7245 10. Кулиев А.А., Джураев М.Д. и др. // Academic research in educational sciences scientific journal 2021. №2. C 291-307 11. Кулиев А.А., Джураев М.Д. и др. // Журнал биомедицины и практики; №2 2021. C 132-138. 12. Kuliev A.A., Juraev M.D. и др. // The American Journal of Medical Sciences and Pharmaceutical Research (ISSN – 2689-1026) 2023. C 70-77.